Less than 4% of ARO patients harbors loss-of-function mutations of TNFSF11, encoding RANK-L, or of TNFRSF11A, encoding RANK receptor, and constitute a distinct subgroup of recessive osteopetrosis. Here, TNFSF11 is linked to osteopetrosis.